{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:26:52Z","timestamp":1782847612473,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Neisseria gonorrhoeae<\/jats:italic>, the causative agent for sexually transmitted infection (STI) gonorrhoea, has emerged with a significant public health impact on acquiring resistance to antimicrobials available for treatment. The resistance of<jats:italic>N. gonorrhoeae<\/jats:italic>limit treatment options and contributed to high morbidity associated with gonorrhoea. Data on antimicrobial resistance (AMR) profiles in<jats:italic>N. gonorrhoeae<\/jats:italic>is scares in Zambia. This study aimed to determine the antibiotic susceptibilities in<jats:italic>N. gonorrhoeae<\/jats:italic>isolates from Lusaka, Zambia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospective cross-sectional study was conducted on 630 STI patients who presented with urethral or vaginal discharge from 2019 to 2020. Urethral and endocervical secretions were cultured on Modified Thayer Martin agar and incubated at 36\u00a0\u00b0C\u2009\u00b1\u20091\u00a0\u00b0C in 5% CO<jats:sub>2<\/jats:sub>for 24\u00a0h. Identification of<jats:italic>N. gonorrhoeae<\/jats:italic>isolates was achieved by Gram stain, oxidase, nitrocefin disk, BactiCard<jats:italic>Neisseria<\/jats:italic>, and Viteck\u00ae Compact. The AMR profiles were determined using E-test. Statistical significant was determined by Pearson\u2019s Chi-square test, Mann-Whitney U test, or logistic regression with<jats:italic>p<\/jats:italic>-values of &lt;\u20090.05 indicating significance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 630 patients were recruited of which 46% (290\/630) with the median of 29 years and interquartile range (IQR) of 19\u201339 years were male. The median of the females was 26 years and IQR of 15\u201337 years.<jats:italic>Neisseria gonorrhoeae<\/jats:italic>was isolated from 19.4% (122\/630) patients of which 72.9% (89\/122) were male, with highest prevalence of isolation in the age category of 25\u201334 years. The prevalence of resistance was high to penicillin (85.2%), tetracycline (68.9%) and ciprofloxacin (59.8%) with MIC<jats:sub>90<\/jats:sub>of 32\u00a0\u00b5g\/mL, 8\u00a0\u00b5g\/mL, and 8\u00a0\u00b5g\/mL respectively. The isolates had reduced susceptibility to cefixime (1.6%), spectinomycin (4.9%) and (4.9%) for azithromycin. All isolates were susceptible to ceftriaxone. Risk factors associated with AMR were douching in females (AOR 6.69, 95% CI; 1.11\u201340.31,<jats:italic>p<\/jats:italic>\u2009=\u20090.039), female gender (AOR 7.64, 95% CI; 1.11\u201352.33,<jats:italic>p<\/jats:italic>\u2009=\u20090.048), HIV-positivity (AOR 26.59, 95% CI; 3.67\u2013192.7,<jats:italic>p<\/jats:italic>\u2009=\u20090.005), no condom use or unprotected sex (AOR 5.48, 95% CI; 1.17\u201322.75<jats:italic>p<\/jats:italic>\u2009=\u20090.026), sex trading (AOR 4.19, 95% CI; 1.55\u201311.33,<jats:italic>p<\/jats:italic>\u2009=\u20090.010), and over-counter treatment of ciprofloxacin (AOR 3.44, 95% CI; 1.17\u201322.75,<jats:italic>p<\/jats:italic>\u2009=\u20090.023).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The<jats:italic>N. gonorrhoeae<\/jats:italic>resistance to penicillin, tetracycline and ciprofloxacin was high necessitating revision of the treatment guidelines. However, no resistance to ceftriaxone was detected. Therefore, monitoring of antibiotic resistance remains critical in Zambia.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-022-07674-y","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T05:03:37Z","timestamp":1660280617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antimicrobial resistance of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Urban Hospitals, Lusaka, Zambia"],"prefix":"10.1186","volume":"22","author":[{"given":"Kelvin L.","family":"Sarenje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Ngalamika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret C.","family":"Maimbolwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amon","family":"Siame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sody M.","family":"Munsaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Kwenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"7674_CR1","first-page":"412","volume":"16","author":"M Unemo","year":"2019","unstructured":"Unemo M, Lahra MM, Cole M, Mike S, Galarza P, Ndowa F, Martin I, Dillion JR, Ramon-Pardo R, Bolan G, Wi T. World Health Organisation Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. J PubMed Central. 2019;16:412\u201325.","journal-title":"J PubMed Central"},{"key":"7674_CR2","unstructured":"WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, May 20, 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240027077. Accessed Aug 18, 2021."},{"key":"7674_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st Century: past, evolution, and future. Clin Microbiol Rev. 2014;27:587\u2013613.","journal-title":"Clin Microbiol Rev"},{"key":"7674_CR4","unstructured":"World Health Organisation (WHO). WHO guidelines for the treatment of Neisseria gonorrhoeae. Geneva: WHO; 2016."},{"key":"7674_CR5","first-page":"956462420949126","volume":"2020","author":"M Unemo","year":"2020","unstructured":"Unemo M, Ross J, Serwin AB, Gomberg M, Cusini M, Jensen JS, Unemo M, Ross J, Serwin AB, Gomberg M, Cusini M, Jensen JS. European guideline for the diagnosis and treatment of gonorrhoea in adults. Int J Sexually Transm Dis Acq Immunodef Dis Syndr. 2020;2020:956462420949126.","journal-title":"Int J Sexually Transm Dis Acq Immunodef Dis Syndr."},{"key":"7674_CR6","first-page":"4","volume":"31","author":"H Fifer","year":"2020","unstructured":"Fifer H, Saunders J, Soni S, Sadiq ST, FitzGerald M. UK national guideline for the management of infection with Neisseria gonorrhoeae. Int J Sexually Transm Dis Acq Immunodef Dis Syndr. 2020;31:4\u201315.","journal-title":"Int J Sexually Transm Dis Acq Immunodef Dis Syndr"},{"key":"7674_CR7","unstructured":"World Health Organisation (WHO). Report on global sexually transmitted infection surveillance, 2018. Geneva: WHO; 2018.\u00a0'http:\/\/www.who.int.\/reproductivehealth\/publications\/rtis\/gonorrhoeae-treatment-guidelines\/en\/."},{"key":"7674_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41572-019-0128-6","volume":"5","author":"M Unemo","year":"2019","unstructured":"Unemo M, Seifert HS, Hook EW, Hawkes S, Ndowa F, Dillion JR. Gonorrhoea. Nat Rev Dis Primers. 2019;5:97.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"7674_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4102\/sajhivmed.v20i1.849","volume":"20","author":"S Lowe","year":"2019","unstructured":"Lowe S, Mudzviti T, Mandiriri A, Shamu T, Mudhokwani P, Chimbetete C, et al. Sexually transmitted infections, the silent partner in HIV-infected women in Zimbabwe. South Afr J HIV Med. 2019;20(1):849.","journal-title":"South Afr J HIV Med"},{"key":"7674_CR10","doi-asserted-by":"publisher","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","volume":"14","author":"T Wi","year":"2017","unstructured":"Wi T, Lahra MM, Ndowa F, Bala M, Dillon JR, Ramon-Pardo P, Eremin SR, Bolan G, Unemo M. Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action. PLoS Med. 2017;14:e1002344.","journal-title":"PLoS Med"},{"key":"7674_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"M Unemo","year":"2014","unstructured":"Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27:587\u2013613.","journal-title":"Clin Microbiol Rev"},{"key":"7674_CR12","doi-asserted-by":"publisher","first-page":"e1002366","DOI":"10.1371\/journal.pmed.1002366","volume":"14","author":"E Alirol","year":"2017","unstructured":"Alirol E, Wi TE, Bala M, Bazzo ML, Chen XS, Deal C, Dillon JR, Kularatne R, Heim J, van HooftHuijsduijnen R, Hook EW, Lahra MM, Lewis DA, Ndowa F, Shafer WM, Tayler L, Workowski K, Unemo M, Balasegaram M. Multidrug-resistant gonorrhoea: a research and development roadmap to discover new medicines. PLoS Med. 2017;14:e1002366.","journal-title":"PLoS Med"},{"key":"7674_CR13","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","volume":"17","author":"M Unemo","year":"2017","unstructured":"Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D, Marrazzo JM, Sonder GJB, Schwebke JR, Hoornenborg E, Peeling RW, Philip SS, Low N, Fairley CK. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017;17:e235\u201379.","journal-title":"Lancet Infect Dis"},{"key":"7674_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrmicro3217","volume":"12","author":"MML Namraj Goire","year":"2014","unstructured":"Namraj Goire MML, Chen M, Donovan B, Christopher K, Fairley RG, Kaldor J, Regan D, Ward J, Nissen MD, Sloots TP, Whiley DM. Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance. Nat Rev Microbiol. 2014;12:223\u20139.","journal-title":"Nat Rev Microbiol"},{"key":"7674_CR15","unstructured":"Amanda B. Gonorrhea. 2008. http:\/\/www.austincc.edu\/microbio\/2704w\/ng. Accessed 22 Mar 2018."},{"key":"7674_CR16","unstructured":"WHO. Sexual and reproductive health: WHO; 2017. http:\/\/www.who.int\/reproductivehealth\/topics\/rtis\/amr-gonorrhoea-on-the-rise\/en\/. Accessed 22 Mar 2018."},{"issue":"8","key":"7674_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/sextrans-2013-051118","volume":"89","author":"B Liu","year":"2013","unstructured":"Liu B, Roberts CL, Clarke M, Jorm L, Hunt J, Ward J. Chlamydia and gonorrhoea infections and the risk of adverse obstetric outcomes: a retrospective cohort study. Sex Transm Infect. 2013;89(8):672\u20138.","journal-title":"Sex Transm Infect"},{"issue":"2","key":"7674_CR18","first-page":"98","volume":"69","author":"GG Donders","year":"1993","unstructured":"Donders GG, Desmyter J, De Wet DH, Van Assche FA. The association of gonorrhoea and syphilis with premature birth and low birth weight. Genitourin Med. 1993;69(2):98.","journal-title":"Genitourin Med"},{"issue":"3","key":"7674_CR19","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/0002-9378(92)91369-L","volume":"166","author":"GL Maxwell","year":"1992","unstructured":"Maxwell GL, Watson WJ. Preterm premature rupture of membranes: results of expectant management in patients with cervical cultures positive for group B streptococcus or Neisseria gonorrhoeae. Am J Obstet Gynecol. 1992;166(3):945\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"7674_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/cid\/cit437","volume":"57","author":"P Pathela","year":"2013","unstructured":"Pathela P, Braunstein SL, Blank S, Schillinger JA. HIV incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry. Clin Infect Dis. 2013;57(8):1203\u20139.","journal-title":"Clin Infect Dis"},{"key":"7674_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1071\/SH19061","volume":"16","author":"RD Kirkcaldy","year":"2019","unstructured":"Kirkcaldy RD, Weston E, Segurado AC, Hughes D. Epidemiology of gonorrhoea: a global perspective. J Sex Health. 2019;16:401\u201311.","journal-title":"J Sex Health"},{"key":"7674_CR22","unstructured":"Elias JF, Vogel U. Manual of clinical microbiology. In: Carroll CC et al. (eds) 12th edn. vol. 1.\u00a0 American Society for Microbiology.\u00a02019.\u00a0pp.\u00a0 640\u2013655."},{"key":"7674_CR23","unstructured":"Hook EW 3rd, Handsfield HH. Sexually transmitted diseases. In: Holmes KK et al. (eds)\u00a0This comprehensive chapter describes different clinical manifestations of gonorrhoea. McGraw- Hill Education\u00a02008;\u00a04th pp. 627\u2013645"},{"key":"7674_CR24","unstructured":"Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections - Management and treatment of specific infections - Gonococcal Infections (Government of Canada, Ottawa, 2013) (modified Sept 2017)."},{"key":"7674_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3390\/vaccines9040327","volume":"9","author":"APR Costa-Louren\u00e7o","year":"2021","unstructured":"Costa-Louren\u00e7o APR, Su X, Le W, Yang Z, Patts GJ, Massari P, Genco CA. Epidemiological and clinical observations of gonococcal infections in women and prevention strategies. Vaccines. 2021;9:327.","journal-title":"Vaccines"},{"key":"7674_CR26","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.3389\/fimmu.2018.03187","volume":"9","author":"A Lovett","year":"2019","unstructured":"Lovett A, Duncan JA. Human immune responses and the natural history of Neisseria gonorrhoeae infection. Front Immunol. 2019;9:3187.","journal-title":"Front Immunol"},{"key":"7674_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/MOH.0000000000000394","volume":"25","author":"JS Stevens","year":"2018","unstructured":"Stevens JS, Criss AK. Pathogenesis of Neisseria gonorrhoeae in the female reproductive tract: neutrophilic host response, sustained infection, and clinical sequelae. Curr Opin Hematol. 2018;25:13\u201321.","journal-title":"Curr Opin Hematol"},{"key":"7674_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrmicro3217","volume":"12","author":"N Goire","year":"2014","unstructured":"Goire N, Lahra MM, Chen M, et al. Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance. Nat Rev Microbiol. 2014;12:223\u20139.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"7674_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s13104-016-2247-4","volume":"9","author":"S Ali","year":"2016","unstructured":"Ali S, Sewunet T, Sahlemariam Z, Kibru G. Neisseria gonorrhoeae among suspects of sexually transmitted infection in Gambella hospital, Ethiopia: risk factors and drug resistance. BMC Res Notes. 2016;9(1):439.","journal-title":"BMC Res Notes."},{"issue":"5","key":"7674_CR30","doi-asserted-by":"publisher","first-page":"e1005611","DOI":"10.1371\/journal.ppat.1005611","volume":"12","author":"SM Fingerhuth","year":"2016","unstructured":"Fingerhuth SM, Bonhoeffer S, Low N, Althaus CL. Antibiotic-resistant Neisseria gonorrhoeae spread faster with more treatment. Not More Sexual Partners PLoS Pathog. 2016;12(5):e1005611.","journal-title":"Not More Sexual Partners PLoS Pathog"},{"key":"7674_CR31","volume-title":"Neisseria gonorrhoeae","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance. In: Neisseria gonorrhoeae. Geneva: World Health Organization; 2012. 97892 41503 501\/ en\/."},{"key":"7674_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/sti.75.1.3","volume":"75","author":"DT Fleming","year":"1999","unstructured":"Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75:3\u201317.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"7674_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/QAI.0b013e3181c3ef29","volume":"53","author":"KT Bernstein","year":"2010","unstructured":"Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD. Rectal gonorrhoea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr. 2010;53(4):537\u201343.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"7674_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/sti.2004.010249","volume":"81","author":"ST Sadiq","year":"2005","unstructured":"Sadiq ST, Taylor S, Copas AJ, Bennett J, Kaye S, Drake SM, et al. The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy. Sex Transm Infect. 2005;81(2):120\u20133.","journal-title":"Sex Transm Infect"},{"issue":"Suppl 6","key":"7674_CR35","doi-asserted-by":"crossref","first-page":"e25355","DOI":"10.1002\/jia2.25355","volume":"22","author":"MS Cohen","year":"2019","unstructured":"Cohen MS, Council OD, Chen JS. Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy. J Int AIDS Soc. 2019;22(Suppl 6):e25355.","journal-title":"J Int AIDS Soc"},{"key":"7674_CR36","unstructured":"National Department of Health Republic of South Africa. First line comprehensive management and control of sexually transmitted infections (STIs). Protocol for the management of a person with a sexually transmitted infection. https:\/\/www.fidssa.co.za\/Guidelines. 2010."},{"issue":"2","key":"7674_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/0255-0857.180278","volume":"34","author":"R Verma","year":"2016","unstructured":"Verma R, Sood S. Gonorrhoea diagnostics: an update. Indian J Med Microbiol. 2016;34(2):139.","journal-title":"Indian J Med Microbiol."},{"key":"7674_CR38","unstructured":"Ministry of Health, Zambia National Formulary Committee. \u00a0Standard Treatment Guidelines, Essential Medicines List, Essential Laboratory Supplies for Zambia, 5th edition. Zambia Ministry of Health, Lusaka. 2020.\u00a0https:\/\/www.moh.gov.zm"},{"issue":"7","key":"7674_CR39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1586\/eri.09.63","volume":"7","author":"JW Tapsall","year":"2009","unstructured":"Tapsall JW, Ndowa F, Lewis DA, Unemo M. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7(7):821\u201334.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"7674_CR40","volume-title":"Performance standards for antimicrobial susceptibility testing. CLSI-M100","author":"Clinical and Laboratory Standards Institute","year":"2021","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI-M100. 31st ed. Wayne (PA): Clinical and Laboratory Standards Institute; 2021.","edition":"31"},{"key":"7674_CR41","unstructured":"World Health Organization (WHO). Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: WHO; 2012. https:\/\/apps.who.int\/iris\/handle\/10665\/44863. Accessed 19 July 2020."},{"issue":"4","key":"7674_CR42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/OLQ.0000000000000961","volume":"46","author":"S Rambaran","year":"2019","unstructured":"Rambaran S, Naidoo K, Dookie N, Moodley P, Sturn WA. Resistance profile of Neisseria gonorrhoeae in KwaZulu, South Africa questioning the effect of the currently advocated dual therapy. J Sex Transm Dis. 2019;46(4):266\u201370.","journal-title":"J Sex Transm Dis"},{"key":"7674_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12905-019-0834-y","volume":"19","author":"TE Hamoonga","year":"2019","unstructured":"Hamoonga TE, Olowski P, Musonda P. Vaginal douching in Zambia: a risk or benefit in women in the fight against cervical cancer: a retrospective cohort study. BMC Women\u2019s Health. 2019;19:135.","journal-title":"BMC Women\u2019s Health"},{"key":"7674_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S2352-4642(20)30335-7","volume":"5","author":"K Martin","year":"2021","unstructured":"Martin K, Olaru DI, Buwu N, Bandason T, Marks M, Dauya E, Muzangwa J, et al. Uptake of and factors associated with testing for sexually transmitted infections in community-based settings among youth in Zimbabwe: a mixed-methods study. Lancet Child Adolesc Health. 2021;5:122\u201332.","journal-title":"Lancet Child Adolesc Health"},{"key":"7674_CR45","doi-asserted-by":"crossref","unstructured":"Martin K, Olaru DI, Buwu N, Bandason T, Marks M, Dauya E, et al. Uptake of and factors associated with testing for sexually transmitted infections in community-based settings among youth in Zimbabwe: a mixed method study-methods study. Lancet Child Adolesc Health 2021; 122\u201332.","DOI":"10.1016\/S2352-4642(20)30335-7"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07674-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07674-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07674-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T14:57:38Z","timestamp":1700924258000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07674-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7674"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07674-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"6 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All examined gonococcal isolates were cultured and preserved as part of the routine diagnostics, and information obtained during the study was kept confidential as no patient identification information was available in the study. Informed consent was obtained for all participants in the study. The study including its protocol was approved by Zambia National Health Research Ethics Board (ZNHREB Ref No.E17020), and the University of Zambia Health Sciences Research Ethics Committee (UNZAHREC Ref No. 20190624004). The whole study was carried out in accordance with STI guidelines and regulations at Dermato-venerology Unit at University Teaching Hospital, Lusaka, Zambia, which are in agreement with Declaration with Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"688"}}